The Association of Oxaliplatin-Containing Adjuvant Chemotherapy Duration with Overall and Cancer-Specific Mortality in Individuals with Stage III Colon Cancer: A Population-Based Retrospective Cohort Study.

Purpose: Few studies have examined the relationship between duration of oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer and mortality in routine practice. We examined the association between treatment with 50% versus >85% of a maximal course of adjuvant therapy (eight cycles...

Descripción completa

Detalles Bibliográficos
Publicado en:Current Oncology Vol. 30; no. 7; pp. 6508 - 6533
Autores principales: Sue-Chue-Lam, Colin, Brezden-Masley, Christine, Sutradhar, Rinku, Yu, Amy Y. X., Baxter, Nancy N.
Formato: Journal Article
Publicado: MDPI Jul2023
Acceso en línea:Ver este registro en EBSCOhost